Abstract:Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is because of the higher number of patients with malignancies treated with intensive immunosuppressive therapy regimens as well as their improved survival from formerly fatal bacterial infections, and the rising number of patients undergoing allogeneic haematopoietic stem cell or organ transplantation. Early initiation of effective systemic antifungal treatment is essential for a successful clinical outcome in these patients; however, clinical clues for diagnosis are sparse and early microbiological proof of invasive aspergillosis (IA) is rare. Clinical diagnosis is based on pulmonary CT scan findings and non-culture based diagnostic techniques such as galactomannan or DNA detection in blood or bronchoalveolar lavage samples. Most promising outcomes can be expected in patients at high risk for aspergillosis in whom antifungal treatment has been started pre-emptively, backed up by laboratory and imaging findings. The gold standard of systemic antifungal treatment is voriconazole, which has been proven to be significantly superior to conventional amphotericin B and has led to a profound improvement of survival rates in patients with cerebral aspergillosis. Liposomal amphotericin B at standard dosages appears to be a suitable alternative for primary treatment, while caspofungin, amphotericin B lipid complex or posaconazole have shown partial or complete response in patients who had been refractory to or intolerant of primary antifungal therapy. Combination therapy with two antifungal compounds may be a promising future strategy for first-line treatment. Lung resection helps to prevent fatal haemorrhage in single patients with pulmonary lesions located in close proximity to larger blood vessels, but is primarily considered for reducing the risk of relapse during subsequent periods of severe immunosuppression. Strict reverse isolation appears to reduce the incidence of aspergillosis in allogeneic stem cell transplant recipients and patients with acute myeloid leukaemia undergoing aggressive anticancer therapy. Well designed, prospective randomised studies on infection control measures effective to prevent aspergillosis are lacking. Prophylactic systemic antifungal treatment with posaconazole significantly improves survival and reduces IA in acute myeloid leukaemia patients and reduces aspergillosis incidence rates in patients with intermediate-to-severe graft-versus-host reaction emerging after allogeneic haematopoietic stem cell transplantation. Voriconazole prophylaxis may be suitable for prevention of IA as well; however, the results of large clinical trials are still awaited.

[Aspergillus infection in skin transplantation and its therapy]

Antifungal resistance mechanisms of Aspergillus.

Aspergillus Infection Limited to the Anastomosed Artery Following Renal Transplantation: a Report of 4 Cases

A Fatal Case of Trichosporon Asahii Fungemia and Pneumonia in a Kidney Transplant Recipient During Caspofungin Treatment.

Aspergillus Infections in Patients Received Lung Transplantation

Primary Cutaneous Aspergillosis Due to Aspergillus Flavus: a Case Report.

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: Retrospective Clinical Analysis from a Tertiary Transplant Center

Necrotizing encephalitis caused by disseminated Aspergillus infection after orthotopic liver transplantation

Fusarium solani species complex infection treated with posaconazole in a liver transplantation patient; a case report

Fungal infection in lung transplantation.

Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients

Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy

Corticosteroids and malnutrition. Aspergillus lung abscess in an asthmatic child

Diagnostics and susceptibility testing in Aspergillus

Renal aspergillosis in a liver transplant patient: A case report and review of literature

Invasive mould infections in the ICU setting: complexities and solutions

Surveillance of Amphotericin B and Azole Resistance in Aspergillus Isolated from Patients in a Tertiary Teaching Hospital

Successful management of wound mucormycosis in a combined hepatic and renal transplant recipient: A case report and literature review